Ouimet Mireille, Hennessy Elizabeth J, van Solingen Coen, Koelwyn Graeme J, Hussein Maryem A, Ramkhelawon Bhama, Rayner Katey J, Temel Ryan E, Perisic Ljubica, Hedin Ulf, Maegdefessel Lars, Garabedian Michael J, Holdt Lesca M, Teupser Daniel, Moore Kathryn J
Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY 10016.
Department of Microbiology, New York University School of Medicine, New York, NY 10016.
Arterioscler Thromb Vasc Biol. 2016 May;36(5):942-951. doi: 10.1161/ATVBAHA.116.307282. Epub 2016 Mar 3.
Cholesterol homeostasis is fundamental to human health and is, thus, tightly regulated. MicroRNAs exert potent effects on biological pathways, including cholesterol metabolism, by repressing genes with related functions. We reasoned that this mode of pathway regulation could be exploited to identify novel genes involved in cholesterol homeostasis.
Here, we identify oxysterol-binding protein-like 6 (OSBPL6) as a novel target of 2 miRNA hubs regulating cholesterol homeostasis: miR-33 and miR-27b. Characterization of OSBPL6 revealed that it is transcriptionally regulated in macrophages and hepatocytes by liver X receptor and in response to cholesterol loading and in mice and nonhuman primates by Western diet feeding. OSBPL6 encodes the OSBPL-related protein 6 (ORP6), which contains dual membrane- and endoplasmic reticulum-targeting motifs. Subcellular localization studies showed that ORP6 is associated with the endolysosomal network and endoplasmic reticulum, suggesting a role for ORP6 in cholesterol trafficking between these compartments. Accordingly, knockdown of OSBPL6 results in aberrant clustering of endosomes and promotes the accumulation of free cholesterol in these structures, resulting in reduced cholesterol esterification at the endoplasmic reticulum. Conversely, ORP6 overexpression enhances cholesterol trafficking and efflux in macrophages and hepatocytes. Moreover, we show that hepatic expression of OSBPL6 is positively correlated with plasma levels of high-density lipoprotein cholesterol in a cohort of 200 healthy individuals, whereas its expression is reduced in human atherosclerotic plaques.
These studies identify ORP6 as a novel regulator of cholesterol trafficking that is part of the miR-33 and miR-27b target gene networks that contribute to the maintenance of cholesterol homeostasis.
胆固醇稳态对人类健康至关重要,因此受到严格调控。微小RNA通过抑制具有相关功能的基因,对包括胆固醇代谢在内的生物途径发挥强大作用。我们推测,这种途径调控模式可用于识别参与胆固醇稳态的新基因。
在此,我们确定了氧甾醇结合蛋白样6(OSBPL6)是调控胆固醇稳态的两个微小RNA枢纽(miR-33和miR-27b)的新靶点。对OSBPL6的特性分析表明,它在巨噬细胞和肝细胞中受肝脏X受体转录调控,对胆固醇负荷有反应,在小鼠和非人灵长类动物中,西式饮食喂养也会影响其表达。OSBPL6编码OSBPL相关蛋白6(ORP6),其包含双膜和内质网靶向基序。亚细胞定位研究表明,ORP6与内溶酶体网络和内质网相关,提示ORP6在这些区室之间的胆固醇转运中发挥作用。相应地,敲低OSBPL6会导致内体异常聚集,并促进这些结构中游离胆固醇的积累,导致内质网处胆固醇酯化减少。相反,ORP6过表达增强巨噬细胞和肝细胞中的胆固醇转运和流出。此外,我们发现,在200名健康个体的队列中,肝脏中OSBPL6的表达与血浆高密度脂蛋白胆固醇水平呈正相关,而在人类动脉粥样硬化斑块中其表达降低。
这些研究确定ORP6是胆固醇转运的新调节因子,是有助于维持胆固醇稳态的miR-33和miR-27b靶基因网络的一部分。